Annual report for Indraprastha Medical Corporation Ltd. for FY-2017
26-05-2017
Board to consider Dividend
Indraprastha Medical Corporation Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 26, 2017, inter alia :-1. to consider and approve, the audited financial results for the quarter/ year ended March 31, 2017, and 2. to consider and recommend dividend, if any, on equity shares of the Company for the financial year 2016-17.08-05-2017
Closure of Trading Window
it is hereby informed that Trading Window shall remain closed from 19th May, 2017 to 29th May, 2017 (both days inclusive) in connection with the aforesaid Board meeting of the Company.08-05-2017
Board Meeting On 26-05-2017
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday, 26th May, 2017, inter alia :- (i)to consider and approve, the audited financial results for the quarter/ year ended 31st March, 2017, and (ii)to consider and recommend dividend, if any, on equity shares of the Company for the financial year 2016-17.08-05-2017
Updates
Enclosed please find a copy of the Notice to the shareholders of the Company published in the newspapers namely Financial Express and Jansatta (Delhi edition) on 22nd April, 2017, in connection with the transfer of shares to Investor Education and Protection Fund (IEPF) pursuant to the provisions of Section 124(6) of the Companies Act, 2013, read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016. This is for your information and records.22-04-2017
Shareholding for the Period Ended March 31, 2017
Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here15-04-2017
Copy Of The Certificate From A Practicing Company Secretary
Ref: IMCL/CS/BSE/2017 13th April, 2017 BSE Ltd., Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Stock Code 532150 Dear Sir, Pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a copy of the certificate from a practicing Company Secretary certifying that all certificates have been issued, for the half year ended 31st March,...13-04-2017
Compliance Certificate For The Half Year Ended 31St March, 2017
Ref: IMCL/CS/BSE/2017 13th April, 2017 BSE Ltd., Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Stock Code 532150 Dear Sir, Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the compliance certificate for the half year ended 31st March, 2017. This is for your information and record. Thanking You, Sincerely Yours, A.K.SINGHAL Encl. As above.13-04-2017
Statement Of Investor Complaints For The Quarter Ended 31St March, 2017
Quarterly Statement of Investor Complaints Name of Listed Entity : INDRAPRASTHA MEDICAL CORPORATION LIMITED Quarter ending : 31ST MARCH, 2017 Complaints pending at the beginning of the quarter 2 Complaints received during the quarter 41 Complaints disposed off during the quarter 43 Complaints lying unresolved at the end of the quarter NIL12-04-2017
Standalone Financial Results, Limited Review Report for December 31, 2016
Indraprastha Medical Corporation Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 201630-01-2017